title: A novel approach for the rapid mutagenesis and directed evolution of the structural genes of west nile virus.
abstract: Molecular clone technology has proven to be a powerful tool for investigating the life cycle of flaviviruses, their interactions with the host, and vaccine development. Despite the demonstrated utility of existing molecular clone strategies, the feasibility of employing these existing approaches in large-scale mutagenesis studies is limited by the technical challenges of manipulating relatively large molecular clone plasmids that can be quite unstable when propagated in bacteria. We have developed a novel strategy that provides an extremely rapid approach for the introduction of mutations into the structural genes of West Nile virus (WNV). The backbone of this technology is a truncated form of the genome into which DNA fragments harboring the structural genes are ligated and transfected directly into mammalian cells, bypassing entirely the requirement for cloning in bacteria. The transfection of cells with this system results in the rapid release of WNV that achieves a high titer (∼10(7) infectious units/ml in 48 h). The suitability of this approach for large-scale mutagenesis efforts was established in two ways. First, we constructed and characterized a library of variants encoding single defined amino acid substitutions at the 92 residues of the "pr" portion of the precursor-to-membrane (prM) protein. Analysis of a subset of these variants identified a mutation that conferred resistance to neutralization by an envelope protein-specific antibody. Second, we employed this approach to accelerate the identification of mutations that allow escape from neutralizing antibodies. Populations of WNV encoding random changes in the E protein were produced in the presence of a potent monoclonal antibody, E16. Viruses resistant to neutralization were identified in a single passage. Together, we have developed a simple and rapid approach to produce infectious WNV that accelerates the process of manipulating the genome to study the structure and function of the structural genes of this important human pathogen.
authors.affiliation: Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: Tsai-Yu
authors.initials: TY
authors.lastname: Lin
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Dowd
authors.forename: Carolyn J
authors.initials: CJ
authors.lastname: Manhart
authors.forename: Steevenson
authors.initials: S
authors.lastname: Nelson
authors.forename: Stephen S
authors.initials: SS
authors.lastname: Whitehead
authors.forename: Theodore C
authors.initials: TC
authors.lastname: Pierson
mesh_terms: D000818:Animals; D002460:Cell Line; D019020:Directed Molecular Evolution / Q000379:methods*; D006801:Humans; D008969:Molecular Sequence Data; D016296:Mutagenesis; D016297:Mutagenesis, Site-Directed / Q000379:methods*; D014759:Viral Envelope Proteins / Q000235:genetics*; D014901:West Nile Fever / Q000821:virology*; D014902:West Nile virus / Q000235:genetics*
chemical_list: D014759:Viral Envelope Proteins